166 related articles for article (PubMed ID: 38058118)
21. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
[TBL] [Abstract][Full Text] [Related]
22. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
23. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
[TBL] [Abstract][Full Text] [Related]
24. The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.
Skirnisdottir I; Seidal T; Åkerud H
Int J Oncol; 2016 Mar; 48(3):998-1006. PubMed ID: 26783205
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and surgical therapy of uterine sarcoma.
Vrzic-Petronijevic S; Likic-Ladjevic I; Petronijevic M; Argirovic R; Ladjevic N
Acta Chir Iugosl; 2006; 53(3):67-72. PubMed ID: 17338203
[TBL] [Abstract][Full Text] [Related]
26. Correlations between reduced expression of the metastasis suppressor gene KAI-1 and accumulation of p53 in uterine carcinomas and sarcomas.
Briese J; Schulte HM; Sajin M; Bamberger C; Redlin K; Milde-Langosch K; Löning T; Bamberger AM
Virchows Arch; 2008 Jul; 453(1):89-96. PubMed ID: 18415123
[TBL] [Abstract][Full Text] [Related]
27. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of prognostic factors in uterine carcinosarcoma.
Nordal RR; Kristensen GB; Stenwig AE; Nesland JM; Pettersen EO; Trope CG
Gynecol Oncol; 1997 Dec; 67(3):316-21. PubMed ID: 9441781
[TBL] [Abstract][Full Text] [Related]
29. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
30. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors associated with uterine sarcomas: the experience of a single institution.
Barquet-Muñoz SA; Isla-Ortiz D; Montalvo-Esquivel G; Cantú-de-León D; Salcedo-Hernández RA; Cordoba-Gonzalez V; Herrera-Gómez Á
J Obstet Gynaecol; 2019 Feb; 39(2):231-236. PubMed ID: 30354797
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of serum CA125 levels with ER, PR, P53 and Ki-67 expression in endometrial carcinomas.
Budak E; Solakoglu Kahraman D; Budak A; Yanarateş A; Inan AH; Kanmaz AG; Beyan E
Ginekol Pol; 2019; 90(12):675-683. PubMed ID: 31909459
[TBL] [Abstract][Full Text] [Related]
33. Does iatrogenic tumor rupture during surgery have prognostic implications for the outcome of uterine sarcomas?
Benito V; Lubrano A; León L; Molano F; Pinar B
Int J Gynecol Cancer; 2020 Nov; 30(11):1726-1732. PubMed ID: 32948637
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population.
Yilmaz N; Sahin I; Kilic S; Ozgu E; Gungor T; Bilge U
Eur J Gynaecol Oncol; 2009; 30(4):412-4. PubMed ID: 19761133
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of serum CA-125 and soluble tumor necrosis factor receptor type I in cervical adenocarcinoma patients.
Kotowicz B; Kaminska J; Fuksiewicz M; Kowalska M; Jonska-Gmyrek J; Gawrychowski K; Sobotkowski J; Skrzypczak M; Starzewski J; Bidzinski M
Int J Gynecol Cancer; 2010 May; 20(4):588-92. PubMed ID: 20686378
[TBL] [Abstract][Full Text] [Related]
36. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
37. Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles.
Ioffe YJ; Li AJ; Walsh CS; Karlan BY; Leuchter R; Forscher C; Cass I
Gynecol Oncol; 2009 Dec; 115(3):466-71. PubMed ID: 19767065
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in uterine sarcoma.
Gadducci A
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
[TBL] [Abstract][Full Text] [Related]
39. Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-institutional Study.
Abdulfatah E; Lordello L; Khurram M; Van de Vijver K; Alosh B; Bandyopadhyay S; Oliva E; Ali-Fehmi R
Int J Gynecol Pathol; 2019 May; 38(3):205-215. PubMed ID: 30958427
[TBL] [Abstract][Full Text] [Related]
40. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
